Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 4, 2017
[Clinical significance of JAK2、CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center]M Y Li, H Y Chao, A N Sun, et al.
Irish Journal of Medical Science|August 10, 2010
Prevalence and clinical significance of 15 autoantibodies in patients with new-onset systemic lupus erythematosusW-X Li, H-F Pan, L-H Li, et al.
Bone Marrow Transplantation|May 29, 2007
Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplantC Liao, J Y Wu, Z P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[CYP2C19 genetic polymorphism and monitoring voriconazole plasma concentrations in the treatment and prevention of invasive fungal disease for hematological patients]H L Qu, D D Guo, T Xu, et al.
Cytotherapy|October 20, 2006
Banking and transplantation of umbilical cord blood in Guangzhou, ChinaJ Y Wu, C Liao, Z P Xu, et al.
Zhonghua Nei Ke Za Zhi|April 9, 2023
[Allogeneic hematopoietic stem cell transplantation in acute leukemia patients with the SET-NUP214 fusion gene: Efficacy and survival analysis]J Xia, Y Zhao, F Chen, et al.
Zhonghua Yi Xue Za Zhi|March 2, 2025
[Efficacy of chemo-free regimen in treatment of six patients with treatment-naive Philadelphia chromosome-positive mixed phenotype acute leukemia]Y Zhang, Y Fan, M M Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 21, 2016
[Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas]Q L Wang, H W Huang, Z M Jin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 28, 2020
[CAR T-cell bridging to allo-HSCT for relapsed/refractory B-cell acute lymphoblastic leukemia: the follow-up outcomes]M Yan, Y J Wu, F Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 7, 2023
[Clinical efficacy and safety of venetoclax combined with multidrug chemotherapy in the treatment of 15 patients with relapsed or refractory early T-cell precursor acute lymphoblastic leukemia]J Y Kong, L H Zong, Y Pu, et al.
Pageof 11